Anti-CXCL10 monoclonal antibodies have implications in infectious disease, chronic inflammatory, and autoimmune disease therapeutics and attenuate murine inflammatory bowel disease and murine AIDS colitis [56]. Here, CXCL10 is linked to autoimmune disease.